Lofexidine Hydrochloride Tablet, Film Coated
Product Images NDC 72205-246

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lofexidine Hydrochloride (NDC 72205-246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lofexi-tab-36s-cntr-lable (Lofexi Tab 36s Cntr Lable)

Lofexi-tab-36s-cntr-lable (Lofexi Tab 36s Cntr Lable)
Label for Lofexidine Tablets 0.18 mg, film-coated oral tablets. The label indicates 36 tablets per container. Lofexidine hydrochloride equivalent to 0.2 mg per tablet is stated. The product is manufactured by MSN Laboratories Private Limited, India, and distributed by Novadoz Pharmaceuticals LLC, Piscataway, NJ. Storage instructions and contact information are included, along with barcodes and NDC 72205-246-42.*
FDA Label Image

Lofexi-tab-36s-crtn-lable (Lofexi Tab 36s Crtn Lable)

Lofexi-tab-36s-crtn-lable (Lofexi Tab 36s Crtn Lable)
Lofexidine Tablets 0.18 mg film-coated oral tablets packaging label. The label indicates a quantity of 36 tablets, labeled for prescription use only with NDC 72205-246-42. Manufactured by MSN Laboratories Private Limited, India, and distributed by Novadoz Pharmaceuticals LLC. The label includes storage instructions and a barcode.*
FDA Label Image

Lofexi-tab-96s-cntr-lable (Lofexi Tab 96s Cntr Lable)

Lofexi-tab-96s-cntr-lable (Lofexi Tab 96s Cntr Lable)
Label for Lofexidine Tablets 0.18 mg film-coated tablets, containing 0.18 mg lofexidine per tablet (equivalent to 0.2 mg lofexidine hydrochloride). The container holds 96 tablets. The product is distributed by Novadoz Pharmaceuticals LLC with manufacturing by MSN Laboratories Private Limited in India. The label includes storage instructions and a barcode.*
FDA Label Image

Lofexi-tab-96s-crtn-lable (Lofexi Tab 96s Crtn Lable)

Lofexi-tab-96s-crtn-lable (Lofexi Tab 96s Crtn Lable)
Packaging label for Lofexidine Tablets 0.18 mg oral film-coated tablets by Novadoz Pharmaceuticals LLC. The label indicates 96 tablets per container, with instructions to store at 25°C (77°F) and protect from heat and moisture. Manufactured by MSN Laboratories Private Limited, India. The product is prescription-only with NDC 72205-246-43.*
FDA Label Image

Lofexi-tab-fig-01 (Lofexi Tab Fig 01)

Lofexi-tab-fig-01 (Lofexi Tab Fig 01)
A Kaplan-Meier survival curve chart showing the proportion of subjects completing a treatment period over study days 1 to 8. It compares three groups: Lofexidine 2.16 mg, Lofexidine 2.88 mg, and Placebo, tracked by different line styles.*
FDA Label Image

Lofexi-tab-fig-02 (Lofexi Tab Fig 02)

Lofexi-tab-fig-02 (Lofexi Tab Fig 02)
A line graph depicting the mean Subjective Opiate Withdrawal Scale (SOWS) total scores over seven study days. It compares three groups: lofexidine 2.16 mg, lofexidine 2.88 mg, and placebo, each with 95% confidence intervals. The x-axis represents study days from 1 to 7, and the y-axis shows the mean SOWS scores, which generally decrease over time.*
FDA Label Image

Lofexi-tab-fig-03 (Lofexi Tab Fig 03)

Lofexi-tab-fig-03 (Lofexi Tab Fig 03)
A Kaplan-Meier curve graph showing the proportion of subjects completing the treatment period over 8 study days, comparing lofexidine 2.88 mg to placebo. The y-axis represents the proportion of subjects, and the x-axis represents study days. The lofexidine group is depicted with a solid line, and the placebo group with a dashed line.*
FDA Label Image

Lofexi-tab-fig-04 (Lofexi Tab Fig 04)

Lofexi-tab-fig-04 (Lofexi Tab Fig 04)
A line graph showing the mean SOWS (Short Opiate Withdrawal Scale) global scores over study days 1 to 5. Two groups are compared: one receiving lofexidine 2.88 mg and the other receiving placebo, both with 95% confidence intervals. The graph shows a decrease in scores over time for both groups, with the lofexidine group starting higher and declining more rapidly.*
FDA Label Image

Lofexi-tab-structure (Lofexi Tab Structure)

Lofexi-tab-structure (Lofexi Tab Structure)
Chemical structure of lofexidine hydrochloride, showing a heterocyclic ring with nitrogen atoms connected to a substituted aromatic ring containing two chlorine atoms and an ether linkage to a methyl group, along with a hydrochloride group (HCl).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.